Pi D W, Raboud J M, Filby C, Carter C J
Metro-McNair Clinical Laboratories, University of British Columbia, Vancouver, Canada.
J Clin Pathol. 1995 Jan;48(1):13-7. doi: 10.1136/jcp.48.1.13.
To examine the magnitude of thromboplastin and coagulometer interactions on the precision of International Normalised Ratio (INR) values when the manufacturers' recommended instrument specific International Sensitivity Index (ISI) values are adopted for the INR calculation.
The variability of INR values obtained from four automated phototopical coagulometers frequently used in North American laboratories was studied. When used with five commercial thromboplastins of moderate to high sensitivity (ISI values 0.92-1.97), 20 prothrombin time results were generated for each of a population of 98 patients on established warfarin treatment.
The mean INR values of the patients ranged from 2.05 to 2.81, depending on which reagent/coagulometer combination was used. Within patient variation increased as the median INR value increased. The mean coefficient of variation of within patient INR values was 10%; the mean coefficient of variation of the prothrombin time results in seconds and prothrombin time ratio were 21 and 18%, respectively.
There was considerable bias in the estimated ISI values of the thromboplastins compared with the manufacturers' instrument specific ISI value. Despite this apparent imperfection, our study clearly showed that the INR is preferable to other prothrombin time reporting formats for assessing the degree of anticoagulation for patients on warfarin treatment.
当采用制造商推荐的仪器特定国际敏感指数(ISI)值进行国际标准化比值(INR)计算时,研究凝血活酶与凝血仪相互作用对INR值精度的影响程度。
研究了北美实验室常用的四种自动光学凝血仪所测得的INR值的变异性。将其与五种中高灵敏度的商业凝血活酶(ISI值为0.92 - 1.97)配合使用时,对98例接受华法林治疗的患者群体中的每一位患者均产生20个凝血酶原时间结果。
患者的平均INR值在2.05至2.81之间,具体取决于所使用的试剂/凝血仪组合。患者体内的变异性随着INR中位数的增加而增大。患者体内INR值的平均变异系数为10%;凝血酶原时间结果(以秒为单位)和凝血酶原时间比值的平均变异系数分别为21%和18%。
与制造商的仪器特定ISI值相比,凝血活酶的估计ISI值存在相当大的偏差。尽管存在这一明显缺陷,但我们的研究清楚地表明,在评估接受华法林治疗患者的抗凝程度时,INR比其他凝血酶原时间报告形式更可取。